Ifytrox-TB 500mg/62.5mg Injection
Marketer
Sanify Healthcare Pvt Ltd
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview Ifytrox-TB 500mg/62.5mg Injection
Combiflox-TB, a 500mg/62.5mg injectable combination drug, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be solely under a healthcare provider's guidance; strict adherence to the prescribed schedule is crucial. Complete the full treatment course, regardless of symptom improvement; premature cessation may compromise efficacy. Nausea, vomiting, diarrhea, and indigestion are potential side effects; worsening symptoms necessitate immediate medical attention. Seek immediate help for allergic reactions (rash, itching, swelling, breathing difficulty). Disclose all current medications to your physician prior to use. Pregnant or lactating individuals require medical consultation before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While driving ability is usually unaffected, avoid driving if drowsiness or dizziness occurs. Adequate rest, proper nutrition, and hydration are vital for optimal recovery. Your doctor may order tests to monitor the medication's impact on your system.
Primary Ingredients of Ifytrox-TB 500mg/62.5mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Ifytrox-TB 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Ifytrox-TB 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Ifytrox-TB 500mg/62.5mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Ifytrox-TB 500mg/62.5mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Ifytrox-TB 500mg/62.5mg Injection works:
Ceftriaxone and Tazobactum, the active components of Ifytrox-TB 500mg/62.5mg Injection, work synergistically to combat bacterial infections. Ceftriaxone's antibiotic action disrupts bacterial cell wall synthesis, hindering their ability to thrive. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Ifytrox-TB 500mg/62.5mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Ifytrox-TB 500mg/62.5mg is generally deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; however, clinical data from human studies are scarce.
Breast feedingCAUTION
The administration of Ifytrox-TB 500mg/62.5mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Ifytrox-TB 500mg/62.5mg Injection can induce drowsiness, visual disturbances, and dizziness, potentially impairing alertness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ifytrox-TB 500mg/62.5mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication, Ifytrox-TB 500mg/62.5mg, requires careful administration to patients exhibiting severe hepatic impairment. Dosage modification may be necessary; physician consultation is advised. Altering the dose of Ifytrox-TB 500mg/62.5mg Injection is unnecessary for individuals with mild or moderate liver dysfunction.
What if you forget to take Ifytrox-TB 500mg/62.5mg Injection :
Omit a dose of Ifytrox-TB 500mg/62.5mg Injection? Seek medical advice immediately.
Facts to Know About Ifytrox-TB 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
3,018 People bought this recently